| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |